Meeting Coverage:

American Academy of Ophthalmology

AAO: 2017

Treatment Options in Patients With Chronic DME

Show Description +

Nathan Radcliffe, MD, provides insight into using sustained medications in patients with chronic diabetic macular edema (DME) and discusses the challenges associated with steroid medications in this population. He also reviews data comparing three IOP-lowering therapies--medications, SLT, and incisional surgery--in patients with chronic DME.

Posted: 11/13/2017

Up Next

Who Should Perform MIGS?

Osamah Saeedi, MD


Hot Topic: Technologies in 2018

Robert Weinstock, MD, Roger Zaldivar, MD

The Future of Cross-linking

William Trattler, MD

Should We Still Be Doing DSAEK?

Winston Chamberlain, MD, PhD

Hot Topic: Pharmaceutical Compounding

Keith Walter, MD, Nathan Radcliffe, MD, Tal Raviv, MD

Hot Topic: Successful Collaborations

Constance Okeke, MD, Greg Parkhurst, MD, John Berdahl, MD

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD

Head-to-Head Trials

Pravin Dugel, MD

Who, What, Where, and When?

Arsham Sheybani, MD, Ike Ahmed, MD

An Update on GATT

Davinder Grover, MD

Who Should Perform MIGS?

Michael Patterson, DO

Hot Topic: Is Astigmatism Correction a Must?

George Waring IV, MD, Neel Desai, MD, Zaina Al-Mohtaseb, MD

Updates on Sjögren Syndrome

Stephen Pflugfelder, MD

Treatment Options in Patients With Chronic DME

Nathan Radcliffe, MD, provides insight into using sustained medications in patients with chronic diabetic macular edema (DME) and discusses the challenges associated with steroid medications in this population. He also reviews data comparing three IOP-lowering therapies--medications, SLT, and incisional surgery--in patients with chronic DME.

Posted: 11/13/2017


Please log in to leave a comment.

More From AAO: 2017 Coverage

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Gene Therapy for Wet AMD

Szilárd Kiss, MD